Taiwanese girls with early puberty who got monthly shots of a drug called leuprolide were more likely to grow taller than their parents' predicted height, especially if they started treatment younger and had more advanced bone growth.

36

Pro

0

Against

Evidence from Studies

Supporting (1)

36

Community contributions welcome

36

Surpassing genetic height potential at final adult height after monthly depot leuprolide therapy in Taiwanese girls with central precocious or early puberty: a ROC-based analysis

Cohort Study

Human

The study looked at the exact same treatment and girls as described in the claim, and found that more than half grew taller than their parents' height predicted, especially when treatment started younger.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Surpassing genetic height potential at final adult height after monthly depot leuprolide therapy in Taiwanese girls with central precocious or early puberty: a ROC-based analysis

Score: 36

DOI: 10.3389/fped.2026.1819205

Similar Assertions

Taiwanese girls with early puberty who keep growing well while on monthly leuprolide shots are more likely to end up taller than their parents' height would predict — by about 6.5 cm on average.

36

0

88%

Girls in Taiwan who start a certain puberty-delaying treatment earlier might end up taller as adults, especially if they start young enough to grow past their parents' expected height — but we can't say for sure what exactly causes the difference.

36

0

86%